SK11352003A3 - Farmaceutický prostriedok - Google Patents

Farmaceutický prostriedok Download PDF

Info

Publication number
SK11352003A3
SK11352003A3 SK1135-2003A SK11352003A SK11352003A3 SK 11352003 A3 SK11352003 A3 SK 11352003A3 SK 11352003 A SK11352003 A SK 11352003A SK 11352003 A3 SK11352003 A3 SK 11352003A3
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
composition according
range
surfactant
active ingredient
Prior art date
Application number
SK1135-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Sven Schreder
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK11352003A3 publication Critical patent/SK11352003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK1135-2003A 2001-02-16 2002-01-23 Farmaceutický prostriedok SK11352003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10107261A DE10107261B4 (de) 2001-02-16 2001-02-16 Pharmazeutische Zusammensetzung
PCT/EP2002/000609 WO2002072100A2 (en) 2001-02-16 2002-01-23 Pharmaceutical composition containing pde v inhibitors and surfactants

Publications (1)

Publication Number Publication Date
SK11352003A3 true SK11352003A3 (sk) 2003-12-02

Family

ID=7674278

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1135-2003A SK11352003A3 (sk) 2001-02-16 2002-01-23 Farmaceutický prostriedok

Country Status (21)

Country Link
US (1) US20040082600A1 (es)
EP (1) EP1385521A2 (es)
JP (1) JP2004519489A (es)
KR (1) KR20030074822A (es)
CN (1) CN1649592A (es)
AR (1) AR032695A1 (es)
BR (1) BR0207271A (es)
CA (1) CA2438401A1 (es)
CZ (1) CZ20032423A3 (es)
DE (1) DE10107261B4 (es)
EC (1) ECSP034769A (es)
EE (1) EE200300378A (es)
HU (1) HUP0303141A3 (es)
IL (1) IL157411A0 (es)
MX (1) MXPA03007318A (es)
PE (1) PE20021039A1 (es)
PL (1) PL364467A1 (es)
RU (1) RU2003127393A (es)
SK (1) SK11352003A3 (es)
WO (1) WO2002072100A2 (es)
ZA (1) ZA200307216B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0518484A2 (pt) * 2004-11-24 2008-11-18 Merck & Co Inc composiÇço, cÁpsula, e, processo para preparar a mesma
US8703786B2 (en) * 2011-12-07 2014-04-22 Texas Southern University Etravirine formulations and uses thereof
JP6943384B2 (ja) * 2017-03-01 2021-09-29 ヱスビー食品株式会社 食品の食感劣化防止用ソフトカプセル、並びに、該食感劣化防止用ソフトカプセル及び食用油を含有する食品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021348A1 (en) * 1991-06-03 1992-12-10 Merck Sharp & Dohme Limited Pharmaceutical formulations of a benzodiazepine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
DE19928146A1 (de) * 1999-06-19 2000-12-21 Merck Patent Gmbh Thienopyrimidine
WO2001051089A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung

Also Published As

Publication number Publication date
IL157411A0 (en) 2004-03-28
MXPA03007318A (es) 2003-12-04
WO2002072100A3 (en) 2003-11-06
PL364467A1 (en) 2004-12-13
CA2438401A1 (en) 2002-09-19
JP2004519489A (ja) 2004-07-02
HUP0303141A3 (en) 2006-05-29
DE10107261B4 (de) 2005-03-10
EE200300378A (et) 2003-10-15
CN1649592A (zh) 2005-08-03
DE10107261A1 (de) 2002-09-12
RU2003127393A (ru) 2005-01-20
CZ20032423A3 (en) 2004-07-14
US20040082600A1 (en) 2004-04-29
PE20021039A1 (es) 2002-11-14
ZA200307216B (en) 2005-01-13
HUP0303141A2 (hu) 2003-12-29
KR20030074822A (ko) 2003-09-19
ECSP034769A (es) 2003-12-24
AR032695A1 (es) 2003-11-19
WO2002072100A2 (en) 2002-09-19
EP1385521A2 (en) 2004-02-04
BR0207271A (pt) 2004-03-23

Similar Documents

Publication Publication Date Title
ES2226976T3 (es) Formulaciones galenicas de fenofibrato y su procedimiento de obtencion.
TWI490216B (zh) 用作ｃ型肝炎病毒蛋白酶抑制劑之醫藥組合物
US20020119198A1 (en) Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
CZ2000157A3 (cs) Samoemulgující formulace pro lipofilní sloučeniny
ES2326783T3 (es) Composiciones de n-benzoilestaurosporina espontaneamente dispersables.
JP2012524820A (ja) 親水性薬剤の自己マイクロエマルジョン化経口医薬組成物およびその調製方法
SK286178B6 (sk) Farmaceutická kompozícia obsahujúca makrolid a kyselinu, spôsob stabilizácie makrolidu proti degradácii a použitie kyseliny na jeho stabilizáciu
SK17222001A3 (sk) Farmaceutické prostriedky obsahujúce cyklosporín
WO2018219804A1 (en) Self-microemulsifying drug delivery systems
RU2639482C2 (ru) Фармацевтические композиции
SK11352003A3 (sk) Farmaceutický prostriedok
JP2002516280A (ja) 新規医薬組成物
ES2325373T3 (es) Composicion farmaceutica destinada a la administracion oral de un derivado de pirazol-3-carboxamida.
JP3748912B2 (ja) オーレオバシジン類の高濃度溶液製剤
JPH07196483A (ja) 経口吸収性を改善した製剤組成物
AU2002234622A1 (en) Pharmaceutical composition containing PDE V inhibitors and surfactants
US20100152244A1 (en) Self-emulsifying formulation of tipranavir for oral administration
CZ20021083A3 (cs) Farmaceutický prostředek
MXPA06005247A (es) Composicion farmaceutica destinada a la administracion oral de un derivado de pirazol-3-carboxamida
HK1102021B (en) Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative
JP2005255677A (ja) シクロスポリン製剤

Legal Events

Date Code Title Description
FC9A Refused patent application